Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001037032 | SCV001200423 | uncertain significance | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2023-05-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 836012). This variant has not been reported in the literature in individuals affected with JUP-related conditions. This variant is present in population databases (rs541560189, gnomAD 0.006%). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 278 of the JUP protein (p.Asn278Ser). |
Fulgent Genetics, |
RCV001037032 | SCV002777641 | uncertain significance | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2021-10-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004761886 | SCV005373020 | uncertain significance | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |